Evaluates tirofiban's effect on outcomes in stroke patients with inadequate response to tenecteplase, suggesting potential improvement.
This study evaluated whether adjunctive intravenous tirofiban improves functional outcomes in patients with acute ischemic stroke without large or medium vessel occlusion or a cardioembolic etiology who show inadequate response to tenecteplase.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: